ORBIMED ADVISORS LLC Insider Trading Transactions
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 19 2019 | SWTX | SpringWorks Therap ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 6,078,103 | 0 | 0 | |
Sep 19 2019 | SWTX | SpringWorks Therap ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 18.00 | 275,000 | 4,950,000 | 7,406,307 | 7.1 M to 7.4 M (+3.86 %) |
Sep 19 2019 | SWTX | SpringWorks Therap ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,053,204 | 0 | 7,131,307 | 6.1 M to 7.1 M (+17.33 %) |
Sep 19 2019 | SWTX | SpringWorks Therap ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 6,078,103 | 0 | 6,078,103 | 0 to 6.1 M |
Aug 09 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 17.90 | 157,636 | 2,821,684 | 2,968,604 | 3.1 M to 3 M (-5.04 %) |
Aug 09 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 17.90 | 492,364 | 8,813,316 | 9,272,225 | 9.8 M to 9.3 M (-5.04 %) |
Aug 08 2019 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.51 | 142,656 | 500,723 | 6,767,584 | 6.6 M to 6.8 M (+2.15 %) |
Jul 01 2019 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.91 | 59,243 | 231,640 | 6,624,928 | 6.6 M to 6.6 M (+0.90 %) |
Jul 01 2019 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.72 | 565,178 | 2,102,462 | 6,565,685 | 6 M to 6.6 M (+9.42 %) |
Jul 01 2019 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.34 | 32,923 | 109,963 | 6,000,507 | 6 M to 6 M (+0.55 %) |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,011,499 | 0 | 0 | |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,099,612 | 0 | 0 | |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,399,000 | 0 | 0 | |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 882,352 | 14,999,984 | 13,822,463 | 12.9 M to 13.8 M (+6.82 %) |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 10,510,111 | 0 | 12,940,111 | 2.4 M to 12.9 M (+432.51 %) |
May 22 2019 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 30.25 | 1,000,000 | 30,250,000 | 1,605,713 | 2.6 M to 1.6 M (-38.38 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,554,466 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 350,000 | 5,250,000 | 2,711,013 | 2.4 M to 2.7 M (+14.82 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 442,438 | 0 | 2,361,013 | 1.9 M to 2.4 M (+23.06 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |
Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 360,000 | 6,480,000 | 2,027,550 | 1.7 M to 2 M (+21.59 %) |
Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
Apr 24 2019 | TPTX | Turning Point Ther ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
Apr 05 2019 | TCDA | Tricida, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 36.00 | 225,000 | 8,100,000 | 11,114,280 | 10.9 M to 11.1 M (+2.07 %) |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Mar 11 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 57.75 | 290,231 | 16,760,840 | 1,471,725 | 1.8 M to 1.5 M (-16.47 %) |
Mar 11 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 55.01 | 68,218 | 3,752,672 | 1,761,956 | 1.8 M to 1.8 M (-3.73 %) |
Feb 19 2019 | AVDR | AVEDRO INC | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 383,746 | 0 | 0 | |
Feb 19 2019 | AVDR | AVEDRO INC | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 333,178 | 0 | 0 | |
Feb 19 2019 | AVDR | AVEDRO INC | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,370,786 | 0 | 0 | |
Feb 19 2019 | AVDR | AVEDRO INC | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 383,746 | 0 | 4,240,128 | 3.9 M to 4.2 M (+9.95 %) |
Feb 19 2019 | AVDR | AVEDRO INC | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 333,178 | 0 | 3,856,382 | 3.5 M to 3.9 M (+9.46 %) |
Feb 19 2019 | AVDR | AVEDRO INC | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,370,786 | 0 | 3,523,204 | 152.4 K to 3.5 M (+2,211.54 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 85,295 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 266,437 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 234,601 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,012,282 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 528,510 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,280,479 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 470,374 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,029,626 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 992,437 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,282,288 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 94,075 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 405,925 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 203,200 | 3,860,800 | 203,200 | 0 to 203.2 K |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 50,561 | 960,659 | 2,455,853 | 2.4 M to 2.5 M (+2.10 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 85,295 | 0 | 2,405,292 | 2.3 M to 2.4 M (+3.68 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 234,601 | 0 | 2,319,997 | 2.1 M to 2.3 M (+11.25 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 528,510 | 0 | 2,085,396 | 1.6 M to 2.1 M (+33.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 470,374 | 0 | 1,556,886 | 1.1 M to 1.6 M (+43.29 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 992,437 | 0 | 1,086,512 | 94.1 K to 1.1 M (+1,054.94 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 94,075 | 0 | 94,075 | 0 to 94.1 K |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 157,939 | 3,000,841 | 10,434,976 | 10.3 M to 10.4 M (+1.54 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 266,437 | 0 | 10,277,037 | 10 M to 10.3 M (+2.66 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,012,282 | 0 | 10,010,600 | 9 M to 10 M (+11.25 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,280,479 | 0 | 8,998,318 | 6.7 M to 9 M (+33.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,029,626 | 0 | 6,717,839 | 4.7 M to 6.7 M (+43.29 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 4,282,288 | 0 | 4,688,213 | 405.9 K to 4.7 M (+1,054.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 405,925 | 0 | 405,925 | 0 to 405.9 K |
Jan 23 2019 | ALPN | ALPINE IMMUNE SCIE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 145,251 | 0 | 145,251 | |
Jan 23 2019 | ALPN | ALPINE IMMUNE SCIE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.37 | 372,439 | 1,999,997 | 3,670,955 | 3.3 M to 3.7 M (+11.29 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,333,206 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,952,719 | 0 | 5,316,355 | 1.4 M to 5.3 M (+289.87 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 11.00 | 1,363,636 | 14,999,996 | 1,363,636 | 0 to 1.4 M |
Dec 13 2018 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 37.60 | 614,772 | 23,115,427 | 0 | 614.8 K to 0 (-100.00 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,352,775 | 0 | 0 | |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,046,943 | 0 | 2,279,023 | |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,678,571 | 0 | 0 | |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.00 | 700,000 | 7,000,000 | 6,466,783 | 5.8 M to 6.5 M (+12.14 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.00 | 490,000 | 4,900,000 | 5,766,783 | 5.3 M to 5.8 M (+9.29 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,279,023 | 0 | 5,276,783 | 3 M to 5.3 M (+76.02 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,997,760 | 0 | 2,997,760 | 0 to 3 M |
Oct 19 2018 | SIBN | SI-BONE, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 179,404 | 0 | 0 | |
Oct 19 2018 | SIBN | SI-BONE, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 572,326 | 0 | 0 | |
Oct 19 2018 | SIBN | SI-BONE, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 200,000 | 3,000,000 | 985,368 | 785.4 K to 985.4 K (+25.47 %) |
Oct 19 2018 | SIBN | SI-BONE, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 179,404 | 0 | 785,368 | 606 K to 785.4 K (+29.61 %) |
Oct 19 2018 | SIBN | SI-BONE, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 605,964 | 0 | 605,964 | 0 to 606 K |
Oct 11 2018 | GH | Guardant Health, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 8,972 | 0 | 0 | |
Oct 11 2018 | GH | Guardant Health, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,525,492 | 0 | 0 | |
Oct 11 2018 | GH | Guardant Health, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 8,972 | 0 | 8,972 | 0 to 9 K |
Oct 11 2018 | GH | Guardant Health, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,525,492 | 0 | 1,525,492 | 0 to 1.5 M |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 544,047 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 260,617 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 312,741 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,070,771 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 250,000 | 4,250,000 | 2,605,713 | 2.4 M to 2.6 M (+10.61 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 167,537 | 0 | 2,355,713 | 2.2 M to 2.4 M (+7.66 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | S | 6.88 | 348,500 | 2,395,938 | 0 | |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | S | 6.88 | 348,500 | 2,395,938 | 0 | |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | S | 3.59 | 1,536,098 | 5,514,592 | 0 | |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 6.88 | 55,000 | 378,125 | 348,500 | |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 6.88 | 55,000 | 378,125 | 348,500 | |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 4.46 | 2,123,098 | 9,469,017 | 0 | 2.1 M to 0 (-100.00 %) |
Sep 07 2018 | STDY | SteadyMed Ltd. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 4.46 | 2,123,098 | 9,469,017 | 0 | 2.1 M to 0 (-100.00 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 1,466 | 14,631 | 69,617 | 71.1 K to 69.6 K (-2.06 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 153,921 | 1,536,132 | 7,310,457 | 7.5 M to 7.3 M (-2.06 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 3,455 | 34,343 | 71,083 | 74.5 K to 71.1 K (-4.64 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 362,765 | 3,605,884 | 7,464,378 | 7.8 M to 7.5 M (-4.63 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.93 | 736 | 7,308 | 74,538 | 75.3 K to 74.5 K (-0.98 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.93 | 77,314 | 767,728 | 7,827,143 | 7.9 M to 7.8 M (-0.98 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 198 | 1,968 | 75,274 | 75.5 K to 75.3 K (-0.26 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 20,777 | 206,523 | 7,904,457 | 7.9 M to 7.9 M (-0.26 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 820 | 8,184 | 75,472 | 76.3 K to 75.5 K (-1.07 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 86,103 | 859,308 | 7,925,234 | 8 M to 7.9 M (-1.07 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 249 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 26,139 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 431 | 3,457 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 45,203 | 362,528 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 184 | 920 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 19,372 | 96,860 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 6,460 | 64,342 | 75,573 | 82 K to 75.6 K (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 678,333 | 6,756,197 | 7,935,856 | 8.6 M to 7.9 M (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.86 | 249 | 2,455 | 82,033 | 82.3 K to 82 K (-0.30 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.86 | 26,139 | 257,731 | 8,614,189 | 8.6 M to 8.6 M (-0.30 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.91 | 615 | 6,095 | 82,282 | 82.9 K to 82.3 K (-0.74 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.91 | 64,575 | 639,938 | 8,640,328 | 8.7 M to 8.6 M (-0.74 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 431 | 2,155 | 82,897 | 82.5 K to 82.9 K (+0.52 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 45,203 | 226,015 | 8,704,903 | 8.7 M to 8.7 M (+0.52 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 184 | 920 | 82,466 | 82.3 K to 82.5 K (+0.22 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 19,372 | 96,860 | 8,659,700 | 8.6 M to 8.7 M (+0.22 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.95 | 1,036 | 10,308 | 82,282 | 83.3 K to 82.3 K (-1.24 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.95 | 108,729 | 1,081,854 | 8,640,328 | 8.7 M to 8.6 M (-1.24 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.00 | 4,553 | 45,530 | 83,318 | 87.9 K to 83.3 K (-5.18 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.00 | 478,107 | 4,781,070 | 8,749,057 | 9.2 M to 8.7 M (-5.18 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 0.00 | 249 | 0 | 87,871 | 87.6 K to 87.9 K (+0.28 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 0.00 | 26,139 | 0 | 9,227,164 | 9.2 M to 9.2 M (+0.28 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 249 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 26,139 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 431 | 3,457 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 45,203 | 362,528 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 184 | 920 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 19,372 | 96,860 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 6,460 | 64,342 | 75,573 | 82 K to 75.6 K (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 678,333 | 6,756,197 | 7,935,856 | 8.6 M to 7.9 M (-7.87 %) |